×

Use of chimeric antigen receptor modified cells to treat cancer

  • US 10,654,934 B2
  • Filed: 02/15/2018
  • Issued: 05/19/2020
  • Est. Priority Date: 04/01/2016
  • Status: Active Grant
First Claim
Patent Images

1. A chimeric antigen receptor (CAR), wherein the CAR comprises an extracellular domain, a transmembrane domain, and an intracellular domain, and wherein the extracellular domain comprises amino acid sequence SEQ ID NO:

  • 5.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×